Aligos Therapeutics, Inc. (ALGS) vs Neuphoria Therapeutics Inc. (NEUP)
- Aligos Therapeutics, Inc. ALGS 2.10 +6.06%
- Neuphoria Therapeutics Inc. NEUP 2.55 −1.16%
Aligos Therapeutics, Inc. and Neuphoria Therapeutics Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and Neuphoria Therapeutics Inc. are of similar size ($14.0M and $14.0M). Neuphoria Therapeutics Inc. grew revenue faster over the last twelve months: 3,535.1% against 1,171.6%. Neuphoria Therapeutics Inc. has the higher net margin (0.00% vs −197.0%) and the lower return on invested capital (−232.7% vs 0.00%). Across the 17 metrics below, Neuphoria Therapeutics Inc. leads on 11 and Aligos Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ALGS | NEUP | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 67.24% |
| Operating margin | (215.55%) | 0.00% | 0.00% |
| Net margin | (197.01%) | 0.00% | 0.00% |
| Free cash flow margin | (204.07%) | 0.00% | 0.00% |
| Return on equity | (159.46%) | (61.70%) | (50.28%) |
| Return on assets | (84.46%) | (46.95%) | (45.89%) |
| Return on invested capital | 0.00% | (232.67%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack